Evogene Ltd
(NASDAQ: EVGN)

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

1.110

+0.010 (+0.91%)
Range 1.095 - 1.140   (4.11%)
Open 1.100
Previous Close 1.100
Bid Price 0.620
Bid Volume 11
Ask Price 0.630
Ask Volume 13
Volume 17,530
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 04:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis